Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States-Reference-Cited by-同舟云学术

Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States

Published:2019-05-14 Issue:7 Volume:8 Page:3420-3427
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Tavakkoli Anna¹^ORCID,Singal Amit G.¹,Waljee Akbar K.²³⁴,Scheiman James M.⁵,Murphy Caitlin C.⁶,Pruitt Sandi L.⁶,Xuan Lei⁶,Kwon Richard S.³,Law Ryan J.³,Elta Grace H.³,Wright‐Slaughter Phyllis⁷,Valley Thomas S.⁸,Kubiliun Nisa¹,Nathan Hari⁹,Rubenstein Joel H.³,Elmunzer B. Joseph¹⁰

Affiliation:

1. Division of Digestive and Liver Diseases, Department of Internal Medicine University of Texas Southwestern Dallas Texas

2. VA Center for Clinical Management Research VA Ann Arbor Health Care System Ann Arbor Michigan

3. Division of Gastroenterology and Hepatology, Department of Internal Medicine Michigan Medicine Ann Arbor Michigan

4. Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP) Ann Arbor Michigan

5. Division of Gastroenterology University of Virginia Charlottesville Virginia

6. Department of Clinical Sciences University of Texas Southwestern Dallas Texas

7. Institute for Health Policy and Innovation University of Michigan Ann Arbor Michigan

8. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Michigan Medicine Ann Arbor Michigan

9. Department of Surgery Michigan Medicine Ann Arbor Michigan

10. Division of Gastroenterology and Hepatology, Department of Medicine Medical University of South Carolina Charleston South Carolina

Funder

American Society for Gastrointestinal Endoscopy

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2225

Reference25 articles.

1. Cancer statistics, 2018

2. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

3. Good News–Bad News: Current Status of GI Cancers

4. Neoadjuvant therapy for resectable pancreatic cancer

5. Hepatotoxicity of Chemotherapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Racial disparities in endoscopic retrograde cholangiopancreatography (ERCP) utilization in the United States: are we getting better?;Surgical Endoscopy;2022-08-19

2. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021;Gastroenterology;2022-02

3. Outcomes of endoscopic retrograde cholangio-pancreatography in patients with liver transplant;Clinical and Experimental Hepatology;2022

4. Health Care Disparities and the Future of Pancreatic Cancer Care;Surgical Oncology Clinics of North America;2021-10

5. Timing of endoscopic retrograde cholangiopancreatography in acute biliary pancreatitis without cholangitis: a nationwide inpatient cohort study;Annals of Gastroenterology;2021